Nuvectis Historical Income Statement

NVCT Stock  USD 4.95  0.15  2.94%   
Historical analysis of Nuvectis Pharma income statement accounts such as Other Operating Expenses of 15.1 M can show how well Nuvectis Pharma performed in making a profits. Evaluating Nuvectis Pharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nuvectis Pharma's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Nuvectis Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nuvectis Pharma is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.

About Nuvectis Income Statement Analysis

Nuvectis Pharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nuvectis Pharma shareholders. The income statement also shows Nuvectis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Nuvectis Pharma Income Statement Chart

At this time, Nuvectis Pharma's Interest Expense is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 668.9 K in 2024, whereas Other Operating Expenses is likely to drop slightly above 15.1 M in 2024.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nuvectis Pharma. It is also known as Nuvectis Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Nuvectis Pharma income statement and is an important metric when analyzing Nuvectis Pharma profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.
Most accounts from Nuvectis Pharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nuvectis Pharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.At this time, Nuvectis Pharma's Interest Expense is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 668.9 K in 2024, whereas Other Operating Expenses is likely to drop slightly above 15.1 M in 2024.
 2010 2022 2023 2024 (projected)
Interest Income4K149K475K498.8K
Net Interest Income4K149K475K498.8K

Nuvectis Pharma income statement Correlations

-0.61-0.6-0.590.660.650.67-0.590.66-0.940.66-0.3-0.91-0.910.810.79-0.76-0.75
-0.610.981.0-0.98-0.98-0.981.0-0.980.8-0.98-0.490.830.83-0.88-0.890.930.93
-0.60.980.99-0.96-0.96-0.960.99-0.960.74-0.96-0.380.760.76-0.8-0.80.850.85
-0.591.00.99-0.98-0.99-0.981.0-0.990.77-0.98-0.490.80.8-0.86-0.870.90.91
0.66-0.98-0.96-0.981.01.0-0.981.0-0.841.00.43-0.87-0.870.910.92-0.92-0.92
0.65-0.98-0.96-0.991.01.0-0.991.0-0.831.00.45-0.86-0.860.910.91-0.92-0.91
0.67-0.98-0.96-0.981.01.0-0.981.0-0.841.00.43-0.87-0.870.920.92-0.92-0.92
-0.591.00.991.0-0.98-0.99-0.98-0.990.77-0.98-0.490.80.8-0.86-0.870.90.91
0.66-0.98-0.96-0.991.01.01.0-0.99-0.831.00.44-0.86-0.860.910.91-0.92-0.92
-0.940.80.740.77-0.84-0.83-0.840.77-0.83-0.84-0.041.01.0-0.96-0.960.930.92
0.66-0.98-0.96-0.981.01.01.0-0.981.0-0.840.43-0.86-0.860.910.92-0.92-0.92
-0.3-0.49-0.38-0.490.430.450.43-0.490.44-0.040.43-0.11-0.110.30.33-0.38-0.39
-0.910.830.760.8-0.87-0.86-0.870.8-0.861.0-0.86-0.111.0-0.98-0.970.950.94
-0.910.830.760.8-0.87-0.86-0.870.8-0.861.0-0.86-0.111.0-0.98-0.970.950.94
0.81-0.88-0.8-0.860.910.910.92-0.860.91-0.960.910.3-0.98-0.981.0-0.98-0.97
0.79-0.89-0.8-0.870.920.910.92-0.870.91-0.960.920.33-0.97-0.971.0-0.98-0.98
-0.760.930.850.9-0.92-0.92-0.920.9-0.920.93-0.92-0.380.950.95-0.98-0.981.0
-0.750.930.850.91-0.92-0.91-0.920.91-0.920.92-0.92-0.390.940.94-0.97-0.981.0
Click cells to compare fundamentals

Nuvectis Pharma Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nuvectis Stock Analysis

When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.